FolioLanternBeta
TXG10x Genomics, Inc.

Shehnaaz Suliman

Director at 10x Genomics, Inc., as of Sep 24, 2026Sold $792K of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 16, 2026 from SEC filings · covers Oct 17, 2025 to Oct 16, 2026
14K
shares sold, past 12 months
3
days with sales
$465K
largest single day, Sep 22, 2026
1
company filed for

Share of stake sold and shares held at 10x Genomics, Inc. are being verified and not shown yet. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMarAprMayJun 2026: $187K under a disclosed planJunJulAug 2026: $140K under a disclosed planAugSep 2026: $465K under a disclosed plan$465KSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
10x Genomics, Inc. (TXG)DirectorSep 11, 2019Sep 24, 2026

Recent filings

The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.